The Clinical Research Coordinator II will play a crucial role in supporting Phase 3 clinical trials focused on GLP-1 receptor agonists and an AI-assisted patient communication pilot study. These studies are pivotal in developing innovative treatment solutions for obesity management. The Phase 3 trial focuses on evaluating GLP-1 receptor agonists, while the pilot study investigates a bidirectional AI communication system designed to improve medication persistence, patient satisfaction, and provider workload through inbound support and scheduled outbound check-ins. This position involves collaboration with various departments to manage these clinical trials effectively, ensuring adherence to protocols and regulatory requirements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Mid Level
Number of Employees
5,001-10,000 employees